Towards novel processes for the fine-chemical and pharmaceutical industries

In response to the need in the pharmaceutical industry for more complex, chiral molecules, fine-chemical companies are embracing new manufacturing technologies to produce compounds of these specifications. In particular, recent developments in biocatalysis combined with novel process engineering are...

Full description

Saved in:
Bibliographic Details
Published in:Current Opinion in Biotechnology 2002-08, Vol.13 (4), p.352-358
Main Authors: Huisman, Gjalt W, Gray, David
Format: Article
Language:English
Subjects:
biocatalysis
Catalysis
Chemical Industry - methods
Chemical Industry - trends
cofactor regeneration
Directed Molecular Evolution
Drug Industry - methods
Drug Industry - trends
enzyme manipulation
Enzymes - biosynthesis
Enzymes - chemical synthesis
fine-chemicals
pharmaceutical
protein engineering
Protein Engineering - methods
Protein Engineering - trends
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In response to the need in the pharmaceutical industry for more complex, chiral molecules, fine-chemical companies are embracing new manufacturing technologies to produce compounds of these specifications. In particular, recent developments in biocatalysis combined with novel process engineering are providing improved methods for the production of valuable chemical intermediates. In response to the need in the pharmaceutical industry for more complex, chiral molecules, fine-chemical companies are embracing new manufacturing technologies to produce compounds of these specifications.
ISSN:0958-1669
1879-0429
DOI:10.1016/S0958-1669(02)00335-X